1,721,046 research outputs found
La detenzione paterna come fattore di rischio di Parent Abuse: sperimentazione di un modello di intervento per la cogenitorialità
Full text linkObiettivo generale del presente studio è individuare tecniche di intervento innovative per la promozione del benessere del detenuto e del suo nucleo familiare in un’ottica di risocializzazione attraverso la cura delle relazioni.
Nello specifico, gli obiettivi sono:
- Esplorare la diffusione del femomeno del PA nei nuclei familiari con padre detenuto
- Valutare l’efficacia dell’intervento di Parental Enrichment attraverso misurazioni pre e post nelle variabili considerate (stress genitoriale paterno, stili educativi, mentalizzazione paterna)
- Valutare, inoltre, se in seguito all’intervento di Parental Enrichment si rileva un cambiamento nella frequenza di comportamenti PA rispetto a prima dell’intervento
- Esplorare la relazione tra mentalizzazione paterna e comportmenti di PA stess
Supplementary_Material_3_Selective_serotonin_reuptake_inhibitors_and_benzodiazepines_in_Panic_Disorder_treatment__2018-07 – Supplemental material for Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: A meta-analysis of common side effects in acute treatment
No full textSupplemental material, Supplementary_Material_3_Selective_serotonin_reuptake_inhibitors_and_benzodiazepines_in_Panic_Disorder_treatment__2018-07 for Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: A meta-analysis of common side effects in acute treatment by Laiana A Quagliato, Fiammetta Cosci, Richard I Shader, Edward K Silberman, Vladan Starcevic, Richard Balon, Steven L Dubovsky, Carl Salzman, John H Krystal, Steve J Weintraub, Rafael C Freire and Antonio E Nardi in Journal of Psychopharmacology</p
Supplementary_figure_6_2019_formatada – Supplemental material for Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: A meta-analysis of common side effects in acute treatment
No full textSupplemental material, Supplementary_figure_6_2019_formatada for Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: A meta-analysis of common side effects in acute treatment by Laiana A Quagliato, Fiammetta Cosci, Richard I Shader, Edward K Silberman, Vladan Starcevic, Richard Balon, Steven L Dubovsky, Carl Salzman, John H Krystal, Steve J Weintraub, Rafael C Freire and Antonio E Nardi in Journal of Psychopharmacology</p
2019_supplementary_material_2 – Supplemental material for Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: A meta-analysis of common side effects in acute treatment
No full textSupplemental material, 2019_supplementary_material_2 for Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: A meta-analysis of common side effects in acute treatment by Laiana A Quagliato, Fiammetta Cosci, Richard I Shader, Edward K Silberman, Vladan Starcevic, Richard Balon, Steven L Dubovsky, Carl Salzman, John H Krystal, Steve J Weintraub, Rafael C Freire and Antonio E Nardi in Journal of Psychopharmacology</p
Supplementary_figure_5_2019_formatada – Supplemental material for Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: A meta-analysis of common side effects in acute treatment
No full textSupplemental material, Supplementary_figure_5_2019_formatada for Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: A meta-analysis of common side effects in acute treatment by Laiana A Quagliato, Fiammetta Cosci, Richard I Shader, Edward K Silberman, Vladan Starcevic, Richard Balon, Steven L Dubovsky, Carl Salzman, John H Krystal, Steve J Weintraub, Rafael C Freire and Antonio E Nardi in Journal of Psychopharmacology</p
Supplementary_Material_1__Prisma_Harms_checklist_items_meta-analysis_2018-07-26 – Supplemental material for Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: A meta-analysis of common side effects in acute treatment
No full textSupplemental material, Supplementary_Material_1__Prisma_Harms_checklist_items_meta-analysis_2018-07-26 for Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: A meta-analysis of common side effects in acute treatment by Laiana A Quagliato, Fiammetta Cosci, Richard I Shader, Edward K Silberman, Vladan Starcevic, Richard Balon, Steven L Dubovsky, Carl Salzman, John H Krystal, Steve J Weintraub, Rafael C Freire and Antonio E Nardi in Journal of Psychopharmacology</p
Clinimetric properties of the 21-item Depression, Anxiety and Stress Scales (DASS-21)
Full text linkBackground: The Depression, Anxiety and Stress Scale-21 (DASS-21) is a widely used patient-reported outcome measure. While psychometric properties of the DASS-21 have been studied, insufficient attention has been devoted to the assessment of its clinimetric properties. This study verified the clinimetric properties of the Italian version of the DASS-21 according to Clinimetric Patient-Reported Outcome Measures (CLIPROM) criteria.
Methods: This is a cross-sectional study involving 951 university students from April to September 2020. Participants were asked to fill in the DASS-21 via an online survey. Participation was voluntary. Item Response Theory (IRT) models were used to test dimensionality, scalability, and sensitivity of DASS-21.
Results: IRT analyses showed that the DASS-21 total score was a multidimensional measure of psychological distress. Fit to the Rasch model was achieved after excluding five misfitting items and adjusting the sample size, resulting in a 16-item version of the DASS-21. The 16-item version entailed the clinimetric property of sensitivity but included inter-correlated items. Brief versions of the DASS-21 subscales of depression, anxiety, and stress, which did not include locally dependent items, fitted the Rasch model expectations, and had an acceptable unidimensionality and scalability, were identified.
Conclusion: The 16-item version of the DASS-21 may be used as an overall indicator of dysthymia and should be supplemented with the brief versions of the depression, anxiety, and stress subscales, which were found to be valid clinimetric indices
- …
